BQ-A represents the first in a class of tissue regulatory state modifiers, which interact with the control apparatus of the genome to affect disease cure. (read more)
BQ-A In-Vivo Studies
BQ-A has been administered by several methods including subcutaneously, intraperitoneally, intratumorally, and topically. (read more)
BQ-A Clinical Plans
Bioquark is focusing on generating human clinical data in multiple therapeutic indications of unmet medical need. (read more)